Preferred Label : Personalized Synthetic Long Peptide Breast Cancer Vaccine;
NCIt definition : A cancer vaccine consisting of one or more long, synthetic peptides derived from patient-specific
breast cancer tumor-associated antigens (TAAs), with potential immunomodulating and
antineoplastic activities. Upon intramuscular administration of the personalized synthetic
long peptide breast cancer vaccine, the peptides stimulate the host immune system
to mount a cytotoxic T-lymphocyte (CTL) response against tumor cells expressing the
TAAs, which results in tumor cell lysis.;
Origin ID : C121947;
UMLS CUI : C4054189;
Semantic type(s)
- concept_is_in_subset
